# ThorGene

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/thorgene

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.thorgene.com
- Latest round: Series A (Jan 14, 2016)
- Investors on record: 1

## About

Established in 2011 and based in Beijing, China, ThorGene is a gene technology company that provides molecular diagnosis and treatment services based on big data technology. The company is headquartered in Beijing and has branches in Nanjing and Suzhou.

The company's main business is providing customized and precise health and medical services through genetic testing and data analysis. The company's self-developed platforms and technologies include a multidimensional life data analysis platform, medical data analysis technology, liquid tumor biopsy technology, and highly sensitive digital PCR instruments. Its products are used in the field of precision medicine, offering solutions for disease prevention and tumor clinical testing.

The company generates revenue by offering a comprehensive suite of genetic testing services, data analysis solutions, and precision health management.

## Funding rounds

- Series A, Jan 14, 2016 — Shenzhen Capital Real Estate Fund

## Investors

- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Series A